(1S,3S,4R,5S)-3-HYDROXY-4-HYDROXYMETHYL-1-(6-AMINOPURIN-9-YL)-BICYCLO-[3.1.0]-HEXANE
Compound with spectra: 1 NMR
![(1S,3S,4R,5S)-3-HYDROXY-4-HYDROXYMETHYL-1-(6-AMINOPURIN-9-YL)-BICYCLO-[3.1.0]-HEXANE](/api/compound/Fs5vwgCbVa7.png?ph=true&h=300&w=458 "(1S,3S,4R,5S)-3-HYDROXY-4-HYDROXYMETHYL-1-(6-AMINOPURIN-9-YL)-BICYCLO-[3.1.0]-HEXANE")
| SpectraBase Compound ID | Fs5vwgCbVa7 |
|---|---|
| InChI | InChI=1S/C12H15N5O2/c13-10-9-11(15-4-14-10)17(5-16-9)12-1-7(12)6(3-18)8(19)2-12/h4-8,18-19H,1-3H2,(H2,13,14,15) |
| InChIKey | OXVNWUDHLNBZRB-UHFFFAOYSA-N |
| Mol Weight | 261.28 g/mol |
| Molecular Formula | C12H15N5O2 |
| Exact Mass | 261.122575 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
8-BrOMOARISTEROMYCIN
RAC-5'-[(ACETYLTHIO)-METHYL]-N(6)-BENZOYL-3'-([(TERT.-BUTYL)-DIPHENYLSILYLOXY]-METHYL)-2',3',5'-TRIDEOXY-1'-A-CARBAADENOSINE;S-(-C-4-[6-
9-[3.beta.-Acetamido-2.beta.-hydroxy-4.alpha.-(hydroxymethyl)cyclopent-1.alpha.-yl]-6-dimethylaminopurine
9-[3.beta.-Acetamido-2.alpha.-hydroxy-4.alpha.-(hydroxymethyl)cyclopent-1.alpha.-yl]-6-dimethylaminopurine
(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[(E)-2-(4-methylphenyl)sulfonylethenyl]oxolane-3,4-diol
Kinetin riboside
3'-O-Butyryl-adenosine
c-4-[6'-(Benzoylamino)-9' H-purin-9'-yl]-t-2-{[(t-butyl)diphenylsilyloxy]methyl})cyclopentane-1-ethanol
RAC-N(6)-BENZOYL-3'-([(TERT.-BUTYL)-DIPHENYLSILYLOXY]-METHYL)-2',3',5'-TRIDEOXY-5'-(HYDROXYMETHYL)-1'-A-CARBAADENOSINE;C-4-[6-(BENZOYLAMINO)-9H-PU
ADENOSINE-(5'-PHOSPHORO-1-PIPERIDINIDE)
| Title | Journal or Book | Year |
|---|---|---|
| Conformationally locked carbocyclic nucleosides built on a bicyclo[3.1.0]hexane template with a fixed Southern conformation. Synthesis and antiviral activity | Journal of the Chemical Society, Perkin Transactions 1 | 1997 |